Ankylosing spondylitis

etiology, pathogenesis, and treatments

Wei Zhu, Xuxia He, Kaiyuan Cheng, Linjie Zhang, Di Chen, Xiao Wang, Guixing Qiu, Xu Cao, Xisheng Weng

Research output: Contribution to journalReview article

Abstract

Ankylosing spondylitis (AS), a common type of spondyloarthropathy, is a chronic inflammatory autoimmune disease that mainly affects spine joints, causing severe, chronic pain; additionally, in more advanced cases, it can cause spine fusion. Significant progress in its pathophysiology and treatment has been achieved in the last decade. Immune cells and innate cytokines have been suggested to be crucial in the pathogenesis of AS, especially human leukocyte antigen (HLA)‑B27 and the interleukin‑23/17 axis. However, the pathogenesis of AS remains unclear. The current study reviewed the etiology and pathogenesis of AS, including genome-wide association studies and cytokine pathways. This study also summarized the current pharmaceutical and surgical treatment with a discussion of future potential therapies.

Original languageEnglish (US)
Article number22
JournalBone Research
Volume7
Issue number1
DOIs
StatePublished - Dec 1 2019

Fingerprint

Ankylosing Spondylitis
Spine
Cytokines
Spondylarthropathies
Genome-Wide Association Study
Therapeutics
HLA Antigens
Chronic Pain
Autoimmune Diseases
Joints
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Histology
  • Physiology

Cite this

Zhu, W., He, X., Cheng, K., Zhang, L., Chen, D., Wang, X., ... Weng, X. (2019). Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Research, 7(1), [22]. https://doi.org/10.1038/s41413-019-0057-8

Ankylosing spondylitis : etiology, pathogenesis, and treatments. / Zhu, Wei; He, Xuxia; Cheng, Kaiyuan; Zhang, Linjie; Chen, Di; Wang, Xiao; Qiu, Guixing; Cao, Xu; Weng, Xisheng.

In: Bone Research, Vol. 7, No. 1, 22, 01.12.2019.

Research output: Contribution to journalReview article

Zhu, W, He, X, Cheng, K, Zhang, L, Chen, D, Wang, X, Qiu, G, Cao, X & Weng, X 2019, 'Ankylosing spondylitis: etiology, pathogenesis, and treatments', Bone Research, vol. 7, no. 1, 22. https://doi.org/10.1038/s41413-019-0057-8
Zhu W, He X, Cheng K, Zhang L, Chen D, Wang X et al. Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Research. 2019 Dec 1;7(1). 22. https://doi.org/10.1038/s41413-019-0057-8
Zhu, Wei ; He, Xuxia ; Cheng, Kaiyuan ; Zhang, Linjie ; Chen, Di ; Wang, Xiao ; Qiu, Guixing ; Cao, Xu ; Weng, Xisheng. / Ankylosing spondylitis : etiology, pathogenesis, and treatments. In: Bone Research. 2019 ; Vol. 7, No. 1.
@article{6244da02efca46b8a800ac02b4c95893,
title = "Ankylosing spondylitis: etiology, pathogenesis, and treatments",
abstract = "Ankylosing spondylitis (AS), a common type of spondyloarthropathy, is a chronic inflammatory autoimmune disease that mainly affects spine joints, causing severe, chronic pain; additionally, in more advanced cases, it can cause spine fusion. Significant progress in its pathophysiology and treatment has been achieved in the last decade. Immune cells and innate cytokines have been suggested to be crucial in the pathogenesis of AS, especially human leukocyte antigen (HLA)‑B27 and the interleukin‑23/17 axis. However, the pathogenesis of AS remains unclear. The current study reviewed the etiology and pathogenesis of AS, including genome-wide association studies and cytokine pathways. This study also summarized the current pharmaceutical and surgical treatment with a discussion of future potential therapies.",
author = "Wei Zhu and Xuxia He and Kaiyuan Cheng and Linjie Zhang and Di Chen and Xiao Wang and Guixing Qiu and Xu Cao and Xisheng Weng",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41413-019-0057-8",
language = "English (US)",
volume = "7",
journal = "Bone Research",
issn = "2095-4700",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Ankylosing spondylitis

T2 - etiology, pathogenesis, and treatments

AU - Zhu, Wei

AU - He, Xuxia

AU - Cheng, Kaiyuan

AU - Zhang, Linjie

AU - Chen, Di

AU - Wang, Xiao

AU - Qiu, Guixing

AU - Cao, Xu

AU - Weng, Xisheng

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Ankylosing spondylitis (AS), a common type of spondyloarthropathy, is a chronic inflammatory autoimmune disease that mainly affects spine joints, causing severe, chronic pain; additionally, in more advanced cases, it can cause spine fusion. Significant progress in its pathophysiology and treatment has been achieved in the last decade. Immune cells and innate cytokines have been suggested to be crucial in the pathogenesis of AS, especially human leukocyte antigen (HLA)‑B27 and the interleukin‑23/17 axis. However, the pathogenesis of AS remains unclear. The current study reviewed the etiology and pathogenesis of AS, including genome-wide association studies and cytokine pathways. This study also summarized the current pharmaceutical and surgical treatment with a discussion of future potential therapies.

AB - Ankylosing spondylitis (AS), a common type of spondyloarthropathy, is a chronic inflammatory autoimmune disease that mainly affects spine joints, causing severe, chronic pain; additionally, in more advanced cases, it can cause spine fusion. Significant progress in its pathophysiology and treatment has been achieved in the last decade. Immune cells and innate cytokines have been suggested to be crucial in the pathogenesis of AS, especially human leukocyte antigen (HLA)‑B27 and the interleukin‑23/17 axis. However, the pathogenesis of AS remains unclear. The current study reviewed the etiology and pathogenesis of AS, including genome-wide association studies and cytokine pathways. This study also summarized the current pharmaceutical and surgical treatment with a discussion of future potential therapies.

UR - http://www.scopus.com/inward/record.url?scp=85070207607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070207607&partnerID=8YFLogxK

U2 - 10.1038/s41413-019-0057-8

DO - 10.1038/s41413-019-0057-8

M3 - Review article

VL - 7

JO - Bone Research

JF - Bone Research

SN - 2095-4700

IS - 1

M1 - 22

ER -